The placebo effect in pharmacological treatment of obstructive sleep apnea, a systematic review and meta-analysis.
暂无分享,去创建一个
J. Hedner | D. Zou | L. Grote | K. Stenlöf | E. Hoff
[1] B. Corser,et al. Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway. , 2023, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[2] J. Hedner,et al. Turning Over a New Leaf-Pharmacologic Therapy in Obstructive Sleep Apnea. , 2022, Sleep medicine clinics.
[3] J. Hedner,et al. A Randomized Controlled Trial Exploring Safety and Tolerability of Sulthiame in Sleep Apnea. , 2022, American journal of respiratory and critical care medicine.
[4] G. Parati,et al. Reboxetine plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-week Randomized, Placebo-controlled, Double-Blind Crossover Trial. , 2021, Chest.
[5] C. Juhl,et al. Placebo response and effect in randomized clinical trials: meta-research with focus on contextual effects , 2021, Trials.
[6] T. Gaisl,et al. Night-to-night variability of respiratory events in obstructive sleep apnoea: a systematic review and meta-analysis , 2020, Thorax.
[7] T. Gaisl,et al. Low Repeatability of Epworth Sleepiness Scale After Short Intervals in a Sleep Clinic Population. , 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[8] Luigi Taranto-Montemurro,et al. Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature , 2019, Journal of clinical medicine.
[9] Vorakamol Phoophiboon,et al. A randomized, double-blind, placebo-controlled trial on the effect of intranasal corticosteroid as a treatment for moderate to severe obstructive sleep apnea with coexisting chronic rhinitis , 2019, Sleep and control of breathing.
[10] S. Redline,et al. More than the Sum of the Respiratory Events: Personalized Medicine Approaches for Obstructive Sleep Apnea. , 2019, American journal of respiratory and critical care medicine.
[11] Natalie S Blencowe,et al. RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.
[12] S. Haile,et al. Efficacy of pharmacotherapy for OSA in adults: A systematic review and network meta-analysis. , 2019, Sleep medicine reviews.
[13] Kevin J. Gleason,et al. The role of sham continuous positive airway pressure as a placebo in controlled trials: Best Apnea Interventions for Research Trial. , 2019, Sleep.
[14] L. Colloca. The Placebo Effect in Pain Therapies. , 2019, Annual review of pharmacology and toxicology.
[15] Charlene P. Spiceland,et al. Effects of Medical Therapy on Mild Obstructive Sleep Apnea in Adult Patients. , 2017, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[16] J. Stradling,et al. Minimum important difference of the Epworth Sleepiness Scale in obstructive sleep apnoea: estimation from three randomised controlled trials , 2018, Thorax.
[17] R. Chervin,et al. A randomized, subject and rater-blinded, placebo-controlled trial of dimethyl fumarate for obstructive sleep apnea , 2018, Sleep.
[18] D. McKenzie,et al. Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial , 2018, European Respiratory Journal.
[19] Malcolm Kohler,et al. Challenges and perspectives in obstructive sleep apnoea , 2018, European Respiratory Journal.
[20] A. Campbell,et al. Clinical Reproducibility of the Epworth Sleepiness Scale for Patients With Suspected Sleep Apnea. , 2018, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[21] T. Kaptchuk,et al. Learned immunosuppressive placebo responses in renal transplant patients , 2018, Proceedings of the National Academy of Sciences.
[22] F. Fuchs,et al. Diuretic or sodium-restricted diet for obstructive sleep apnea—a randomized trial , 2018, Sleep.
[23] A. Simonds,et al. The Epworth Sleepiness Scale: Minimum Clinically Important Difference in Obstructive Sleep Apnea. , 2017, American journal of respiratory and critical care medicine.
[24] N. Glozier,et al. A systematic review and meta-analysis of placebo versus no treatment for insomnia symptoms. , 2017, Sleep medicine reviews.
[25] K. Reid,et al. Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea , 2018, Sleep.
[26] G. Duarte,et al. Placebo and nocebo responses in restless legs syndrome , 2017, Neurology.
[27] Niran Hunchaisri,et al. Efficacy of Donepezil in the Treatment of Obstructive Sleep Apnea: A Placebo-Controlled Trial. , 2016, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[28] P. Tsao,et al. Does enhanced insulin sensitivity improve sleep measures in patients with obstructive sleep apnea: a randomized, placebo-controlled pilot study. , 2016, Sleep medicine.
[29] S. Crowe,et al. The Cognitive Effects of Obstructive Sleep Apnea: An Updated Meta-analysis. , 2016, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[30] M. Preisig,et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. , 2015, The Lancet. Respiratory medicine.
[31] K. Franklin,et al. Effects of Radiofrequency versus sham surgery of the soft palate on daytime sleepiness , 2014, The Laryngoscope.
[32] Jiming Liu,et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.
[33] J. Hedner,et al. Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study , 2014, European Respiratory Journal.
[34] R. Bissonnette,et al. Effect of adalimumab on sleep parameters in patients with psoriasis and obstructive sleep apnea: a randomized controlled trial , 2014, The Journal of dermatological treatment.
[35] C. Cingi,et al. The Effects of Mometasone Furoate and Desloratadine in Obstructive Sleep Apnea Syndrome Patients with Allergic Rhinitis , 2013, American journal of rhinology & allergy.
[36] S. Zakynthinos,et al. The effect of nasal tramazoline with dexamethasone in obstructive sleep apnoea patients , 2013, European Respiratory Journal.
[37] R. Velluti,et al. Achyrocline satureioides (LAM) D.C. would improve sleep quality in patients with Obstructive Sleep Apnea Syndrome: a pilot study , 2013 .
[38] J. Ioannidis,et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials , 2011, BMJ : British Medical Journal.
[39] A. Malhotra,et al. Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold. , 2011, Clinical science.
[40] J. Herdegen,et al. Prospective trial of efficacy and safety of ondansetron and fluoxetine in patients with obstructive sleep apnea syndrome. , 2010, Sleep.
[41] B. Gaymard,et al. Proof of concept study: does fenofibrate have a role in sleep apnoea syndrome? , 2010, Current medical research and opinion.
[42] David A. Schulman,et al. Evaluation of sham-CPAP as a placebo in CPAP intervention studies. , 2010, Sleep.
[43] S. Hofmann,et al. Meta-analysis of the placebo response in antidepressant trials. , 2009, Journal of affective disorders.
[44] Anup V. Desai,et al. Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. , 2008, Sleep.
[45] C. Guilleminault,et al. Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. , 2008, Chest.
[46] W. T. McNicholas,et al. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities , 2006, European Respiratory Journal.
[47] H. Basun,et al. A randomized placebo‐controlled trial of an NMDA receptor antagonist in sleep‐disordered breathing , 2005, Journal of sleep research.
[48] E. Bixler,et al. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. , 2004, The Journal of clinical endocrinology and metabolism.
[49] W. McNicholas,et al. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. , 2004, Thorax.
[50] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[51] T. Young,et al. Epidemiology of obstructive sleep apnea: a population health perspective. , 2002, American journal of respiratory and critical care medicine.
[52] L. Knaack,et al. Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity. , 2000, American journal of hypertension.
[53] H. Magnussen,et al. The therapeutic effect of theophylline in mild obstructive sleep Apnea/Hypopnea syndrome: results of repeated measurements with portable recording devices at home. , 2000, European journal of medical research.
[54] D. Navajas,et al. Sham continuous positive airway pressure for placebo-controlled studies in sleep apnoea , 1999, The Lancet.
[55] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[56] D. Köhler,et al. Benzodiazepine receptor antagonist (flumazenil) does not affect sleep-related breathing disorders. , 1996, The European respiratory journal.
[57] R. Duclaux,et al. Naltrexone improves blood gas patterns in obstructive sleep apnoea syndrome through its influence on sleep , 1993, Journal of sleep research.
[58] J. Peter,et al. Senkt Plazebo den nächtlichen Blutdruck bei schlaf bezogenen Atmungsstörungen und arterïeller Hypertonie , 1993 .
[59] E. R. Mcfadden,et al. Influences of Suggestion on Airway Reactivity in Asthmatic Subjects , 1968, Psychosomatic medicine.